Inventor · disambiguated record
Peter Gmeiner
Also filed as: GMEINER PETER
11 granted patents·11 pending applications·33 citations·filing 1987–2022
84Inventor score
Top patents by PatentIndex Score
22 records- 0186US10702498B2MU opioid receptor modulatorsUNIV CALIFORNIA·Filed 2016·Granted Jul 7, 2020·4 cites·28 claims
- 0285US11484525B2Mu opioid receptor modulatorsUNIV CALIFORNIA·Filed 2020·Granted Nov 1, 2022·1 cites·18 claims
- 0379US10780078B2Mu opioid receptor modulatorsUNIV CALIFORNIA·Filed 2018·Granted Sep 22, 2020·3 cites·19 claims
- 0467US7292910B2Method and device for machining a workpieceKUKA ROBOTER GMBH·Filed 2003·Granted Nov 6, 2007·21 cites·19 claims
- 0566US7951796B29-amino-acridine derivatives and their use for eliminating misfolded proteinsKORTH CARSTEN·Filed 2006·Granted May 31, 2011·3 cites·25 claims
- 0657US2025032476A1Alpha-2a adrenergic receptor modulators and uses thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0750US2009209516A19-amino-acridine derivatives and method of treating autoimmune diseases using the sameKORTH CARSTEN·Filed 2008·Application pending·0 cites
- 0849US11590089B2Beta-2 selective adrenergic receptor agonistsUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Feb 28, 2023·0 cites·4 claims
- 0944US2020109126A1Mu opioid receptor modulatorsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1041US7770045B2Method and apparatus for operating cooperating, differing devicesKUKA ROBOTER GMBH·Filed 2004·Granted Aug 3, 2010·0 cites·18 claims
- 1140US2008292051A1Imaging deviceDIPPL THOMAS·Filed 2008·Application pending·0 cites
- 1238US8691839B2Aminotetraline derivativesGMEINER PETER·Filed 2013·Granted Apr 8, 2014·0 cites·13 claims
- 1338US2021353626A1Beta-adrenergic receptor allosteric modulatorsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1435US2020308168A1Fluorophenyl substituted muscarinic receptor ligands with selectivity for m3 over m2UNIV FRIEDRICH ALEXANDER ER·Filed 2018·Application pending·0 cites
- 1534US2010168125A1Indolizines and aza-analog derivatives thereof as cns active compoundsGMEINER PETER·Filed 2008·Application pending·0 cites
- 1634US2007299091A1Azaindole CarboxamidesGMEINER PETER·Filed 2005·Application pending·0 cites
- 1734US2008194539A1Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 AntagonistsSANOL ARZNEI SCHWARZ GMBH·Filed 2005·Application pending·0 cites
- 1832US8586603B2Aminotetraline derivativesGMEINER PETER·Filed 2010·Granted Nov 19, 2013·0 cites·16 claims
- 1931US2005197343A1Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseasesFiled 2003·Application pending·0 cites
- 2027US2008051409A1Indolizine Carboxamides and Aza and Diaza Derivatives ThereofGMEINER PETER·Filed 2005·Application pending·0 cites
- 2122US11180511B2Diagnosis, treatment and prevention of neurotensin receptor-related conditionsFRIEDRICH ALEXANDER UNIV ERLANGEN NURNBERG·Filed 2017·Granted Nov 23, 2021·0 cites·19 claims
- 2216US4859664ADerivatives of 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonines and -1,4-benzoxazonines, processes for their production and their use as pharmaceuticalsMADAUS GMBH & COMPANY·Filed 1987·Granted Aug 22, 1989·1 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →